Skip to main content
OpenTrials
Completed

NCT Number: NCT00000332

High Dose Nimodipine Treatment Adjunct - 1

The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cocaine-Related Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

22 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Washington DC VA

Washington D.C., District of Columbia, 20422, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

Nimodipine

Drug

Primary outcomes

  1. Stimulated and non-stimulated craving

  2. Stimulated and non-stimulated withdrawal

  3. Anxiety, depression

  4. Heart rate

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

  • Washington D.C. Veterans Affairs Medical Center

Registry information

Official study title

High Dose Nimodipine Pharmacotherapy Adjunct

Important dates

Study start
1998
Primary completion
2000
Study completion
2000
First posted
Sep 21, 1999
Registry last updated
Feb 24, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.